NCT03999801 - Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy | Biotech Hunter

Enrollment

865

Participants

Timeline

Start Date

May 31, 2019

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Neovascular Age-related Macular DegenerationWet Macular Degeneration

Interventions

GENETIC

RGX-314

AAV8 vector containing a transgene for anti-VEGF Fab

Trial Locations (9)

University of Pennsylvania Department of Ophthalmology, Philadelphia

MidAtlantic Retina, Philadelphia

Johns Hopkins University, Baltimore

Charles Retina Institute, Germantown

Retina Consultants of Texas Research Center, The Woodlands

Retinal Research Institute, LCC, Phoenix

Sierra Eye Associates, Reno

California Retina Consultants CRC, Santa Barbara

Ophthalmic Consultants of Boston, Boston